Donoghoe Nicholas

Insider profile

Performance

Overall performance
2.5

Performance over holding periods
2.5
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Donoghoe Nicholas's trades of Abbvie Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-08-07 2025-08-05 S Sale
10,878 -35.1%
79.42
US$1,947,590
10,878 -35.1% 79.42 US$1,947,590
2025-08-07 2025-08-05 S Sale
42,519 +35.4%
282.30
US$479,795
42,519 +35.4% 282.30 US$479,795
2025-08-05 2025-08-05 PrS Proposed sale
8,865
28.48
US$604,933
8,865 28.48 US$604,933
2024-03-22 2024-03-20 S Sale
21,082 -27.4%
176.30
US$3,716,757
21,082 -27.4% 176.30 US$3,716,757
2024-03-21 2024-03-20 PrS Proposed sale
21,082
176.31
US$3,716,941
21,082 176.31 US$3,716,941
2024-03-20 2024-03-20 PrS Proposed sale
21,082
176.31
US$3,716,941
21,082 176.31 US$3,716,941
2023-12-28 2023-12-26 S Sale
2,912 -5.0%
154.72
US$450,545
2,912 -5.0% 154.72 US$450,545
2023-12-26 2023-12-26 PrS Proposed sale
2,912
154.73
US$450,574
2,912 154.73 US$450,574